OR4A18P

Across TCGA pan-cancer cohorts, OR4A18P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR4A18P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where OR4A18P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR4A18P is over-expressed in tumor.

BRCA are the cancer types where OR4A18P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR4A18P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.012	.042	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

OR4A18P–BRCA

Open the BRCA breakdown →